Association of Self-Reported Depression on the Lupus Impact Tracker with Glucocorticoid Therapy and Fibromyalgia in Systemic Lupus Erythematosus: Insights from the RELESSER-PROS Registry - Quiz - MDSpire

Association of Self-Reported Depression on the Lupus Impact Tracker with Glucocorticoid Therapy and Fibromyalgia in Systemic Lupus Erythematosus: Insights from the RELESSER-PROS Registry

  • By

  • Inigo Rua-Figueroa

  • Julia Martínez-Barrio

  • Zulema Plaza

  • Norman Jiménez

  • Maria Galindo-Izquierdo

  • Esther Uriarte

  • Antonio Fernandez-Nebro

  • Jaime Calvo Alen

  • José Rosas

  • Javier Narváez

  • Elena Aurrecoechea

  • Mercedes Freire

  • Eva Tomero

  • Clara Sanguesa

  • Carlota Iniguez

  • Ana Perez

  • Sandra Garrote

  • Nuria Lozano-Rivas

  • Oihane Ibarguengoitia

  • Eva Salgado

  • Celia Erausquin

  • Tarek Carlos Salman Monte

  • Raúl Menor

  • Irene Altabás-González

  • Jorge Fragio Gil

  • Joan M. Nolla

  • Jose M. Pego-Reigosa

  • January 24, 2026

  • 0 min

Share

Original Source(s)

Association of Self-Reported Depression on the Lupus Impact Tracker with Glucocorticoid Therapy and Fibromyalgia in Systemic Lupus Erythematosus: Insights from the RELESSER-PROS Registry

  • by Inigo Rua-Figueroa, Julia Martínez-Barrio, Zulema Plaza, Norman Jiménez, Maria Galindo-Izquierdo, Esther Uriarte, Antonio Fernandez-Nebro, Jaime Calvo Alen, José Rosas, Javier Narváez, Elena Aurrecoechea, Mercedes Freire, Eva Tomero, Clara Sanguesa, Carlota Iniguez, Ana Perez, Sandra Garrote, Nuria Lozano-Rivas, Oihane Ibarguengoitia, Eva Salgado, Celia Erausquin, Tarek Carlos Salman Monte, Raúl Menor, Irene Altabás-González, Jorge Fragio Gil , Joan M. Nolla, Jose M. Pego-Reigosa

  • January 24, 2026

Related Content

Migraine with comorbid fibromyalgia: psychological burden and impact on frequency and severity of migraine attacks

Distinct yet Overlapping Functions of TLR7 and TLR9 in Systemic Lupus Erythematosus and Sjögren’s Syndrome

A dynamic vascular–inflammatory–fibrotic loop in systemic sclerosis: an integrative immuno-vascular framework